Content

Past Issues

Download Magazine

Search

Subscribe

  • This field is for validation purposes and should be left unchanged.

Campus News

Dr. Benfield Named First Diversity and Inclusion Chief

Dr. Benfield Named First Diversity and Inclusion Chief

Nerys Benfield, M.D., M.P.H., has been named Einstein’s first senior associate dean for diversity and inclusion. Currently an associate professor of obstetrics & gynecology and women’s health at Einstein and director of family planning and the fellowship in family planning at Montefiore, Dr. Benfield will report directly to Gordon Tomaselli, M.D., the Stanley and Marilyn Katz Dean at Einstein, in her new role.

The creation of this position was the top recommendation of Einstein’s Strategic Plan for Diversity and Inclusion, which reflected the input of more than 90 participants. The plan was launched in 2017 under the deanship of Allen Spiegel, M.D., with leadership from Edward Burns, M.D., executive dean, Irene Blanco, M.D., associate dean for the office of diversity enhancement, and Yvonne Ramirez, vice president of human resources and diversity. Dr. Benfield will work closely with them, as well as with Dorcas Lind, assistant vice president of diversity and inclusion at Montefiore.

She received a bachelor’s degree from Harvard College, an M.D. from the University of California, San Francisco, and a master’s degree in public health from the University of California, Berkeley.

Dr. Benfield arrived at Einstein and Montefiore in 2011 following her fellowship. “I was drawn to the diversity of the staff, faculty, and patients,” she says. She started a diversity and inclusion group in her department and has focused on recruiting at the resident, fellow, and faculty level. Nationally, she co-chairs the diversity, equity, and inclusion group for the Society of Family Planning.

More From Einstein

Class of 2024 Celebrates Match Day
Einstein Community Enjoys Pi Day
Graduate Students Win Marmur Award
Empowering Einstein Women in Science
Einstein Secures $192M in NIH Grants
Training the Next Cancer Researchers
Bringing a Novel Drug to Market
A Promise to Rwandan Genocide Survivors